Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

  1. Das, S.
  2. Finney, A.C.
  3. Anand, S.K.
  4. Rohilla, S.
  5. Liu, Y.
  6. Pandey, N.
  7. Ghrayeb, A.
  8. Kumar, D.
  9. Nunez, K.
  10. Liu, Z.
  11. Arias, F.
  12. Zhao, Y.
  13. Pearson-Gallion, B.H.
  14. McKinney, M.P.
  15. Richard, K.S.E.
  16. Gomez-Vidal, J.A.
  17. Abdullah, C.S.
  18. Cockerham, E.D.
  19. Eniafe, J.
  20. Yurochko, A.D.
  21. Magdy, T.
  22. Pattillo, C.B.
  23. Kevil, C.G.
  24. Razani, B.
  25. Bhuiyan, M.S.
  26. Seeley, E.H.
  27. Galliano, G.E.
  28. Wei, B.
  29. Tan, L.
  30. Mahmud, I.
  31. Surakka, I.
  32. Garcia-Barrio, M.T.
  33. Lorenzi, P.L.
  34. Gottlieb, E.
  35. Salido, E.
  36. Zhang, J.
  37. Orr, A.W.
  38. Liu, W.
  39. Diaz-Gavilan, M.
  40. Chen, Y.E.
  41. Dhanesha, N.
  42. Thevenot, P.T.
  43. Cohen, A.J.
  44. Yurdagul, A.
  45. Rom, O.
  46. Show all authors +
Journal:
Nature Metabolism

ISSN: 2522-5812

Year of publication: 2024

Type: Article

DOI: 10.1038/S42255-024-01134-4 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus